Introduction to Clinical Trials in Drug Development
Speaker(s)
- Steve Ruberg (Eli Lilly and Company)
Description
Drug development by pharmaceutical companies is the major source of new medications entering the marketplace, and clinical trials done by pharma are the primary evidence for marketing approval by regulatory agencies around the world. As such, these trials require the highest level of scientific rigor. This short course will cover the overall structure and process for clinical drug development as well as highlight important scientific/statistical considerations. The course will be presented at a level that does not require in-depth knowledge of statistical theory and methods, but will describe principles for good scientific and statistical practice. Real examples from the pharmaceutical industry will be used to illustrate issues and concepts.
Schedule
Wed, June 20 - Location: RAWL 3058
| Time | Speaker | Title |
|---|---|---|
| 1:30-2:55PM | Steve Ruberg | |
| 3:30-4:55PM | Steve Ruberg | |